Cargando…
Newcastle disease virus co‐expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
Interleukin 15 (IL15) and IL7 are two cytokines essential for T cell development and homeostasis. In order to improve the antitumor activity by Newcastle disease virus (NDV)‐modified tumor vaccine, we generated a recombinant NDV co‐expressing IL15 and IL7 (LX/IL(15+7)) through incorporation of a 2A...
Autores principales: | Xu, Xiaojing, Sun, Qing, Mei, Yu, Liu, Yonghao, Zhao, Lixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797827/ https://www.ncbi.nlm.nih.gov/pubmed/29224228 http://dx.doi.org/10.1111/cas.13468 |
Ejemplares similares
-
Tumor Cells Modified with Newcastle Disease Virus Expressing IL-24 as a Cancer Vaccine
por: Xu, Xiaojing, et al.
Publicado: (2019) -
Interleukin-7 and Interleukin-15 for Cancer
por: Zarogoulidis, Paul, et al.
Publicado: (2014) -
Interleukin 15 in Cell-Based Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022) -
Research progress of interleukin-15 in cancer immunotherapy
por: Cai, Menghan, et al.
Publicado: (2023) -
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors
por: Mortensen, Michael R., et al.
Publicado: (2020)